We work at the level where a cell decides whether to survive. That is a capability that generalizes - across hair, across skin, and toward broader frontiers in how the body maintains itself.
The stem cells responsible for renewing tissue can get stuck and deplete as we age. Recent discoveries have begun to reveal the cellular mechanism behind this process - and, with it, new approaches to regenerating or reversing it. Our first program reads this biology directly, in human tissue.
Your skin evolved over millions of years to keep things out. Our platform moves a small peptide across that barrier and to its destination - described here conceptually, as a capability rather than a formula. Because the delivery approach is cargo-agnostic, it generalizes across programs. That is the differentiator.
We grow human hair follicles and full human scalp explants in the lab, both under Helsinki-committee approval, and visualize them with multi-laser confocal, time-lapse fluorescence, and electron microscopy. These are the systems a serious regenerative-biology lab uses to ask whether something really works.
Demonstrating that a maintenance process can be shifted biologically is the beginning, not the end. The same platform opens onto hair, skin, and further therapeutic frontiers - positioning Elixrbio as a platform company with healthcare-scale ambitions.